| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Monopar Therapeutics | Chief Financial Officer | Common Stock | 1.55K | $10.4K | $6.74 | 28 Oct 2024 | Direct |
| Monopar Therapeutics | Chief Financial Officer | Stock Options | 125K | 01 Jul 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MNPR | Monopar Therapeutics | 28 Oct 2024 | 1 | $25.2K | 4 | Chief Financial Officer | 30 Oct 2024, 16:17 |
| MNPR | Monopar Therapeutics | 01 Jul 2024 | 1 | $0 | 4 | Chief Financial Officer | 03 Jul 2024, 18:22 |
| MNPR | Monopar Therapeutics | 01 Jul 2024 | 0 | $0 | 3 | Chief Financial Officer | 03 Jul 2024, 18:20 |